Some Clinical and Pharmacological Aspects of Community Pneumonia Therapy

Effective Pharmacotherapy

doi 10.33978/2307-3586-2019-15-27-28-36

Full Text

Abstract

Available in

Date

Authors

Publisher

Medforum

Related search

Empiric Therapy of Community-Acquired Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Origanum Majorana Essential Oil: Some Pharmacological and Toxicological Aspects

Biomedical Journal of Scientific & Technical Research
2019English

Low Procalcitonin, Community Acquired Pneumonia, and Antibiotic Therapy

The Lancet Infectious Diseases
Infectious Diseases
2018English

Burden of Community-Acquired Pneumonia and Unmet Clinical Needs

Advances in Therapy
MedicinePharmacology
2020English

Antibacterial Therapy of Community-Acquired Pneumonia in Children

CHILD`S HEALTH
2018English

Community-Acquired and Nosocomial Pneumonia: Clinical and Morphological Features

Obshchaya Reanimatologiya
Critical CareIntensive Care Medicine
2010English

Some Aspects of Treatment for Cognitive Impairments. Cyticolin: Pharmacological Characteristics, Possible Benefits, Aspects of Use

Nevrologiya, Neiropsikhiatriya, Psikhosomatika
PsychiatryClinical PsychologyMental HealthNeurology
2015English

Antimicrobial Therapy for Community-Acquired Pneumonia in Adults

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2002English

Clinical Profile of Recurrent Community-Acquired Pneumonia in Children

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy